Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125983651 | 12598365 | 1 | I | 20160614 | 20160726 | 20160726 | EXP | NZ-ABBVIE-16P-118-1656781-00 | ABBVIE | 61.00 | YR | M | Y | 0.00000 | 20160726 | OT | COUNTRY NOT SPECIFIED | NZ |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125983651 | 12598365 | 1 | PS | VIEKIRA PAK | DASABUVIROMBITASVIRPARITAPREVIRRITONAVIR | 1 | Oral | UNKNOWN | 206619 | TABLET | |||||||||
125983651 | 12598365 | 2 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | UNKNOWN | 0 | TABLET | |||||||||
125983651 | 12598365 | 3 | SS | CANNABIS | CANNABIS SATIVA SUBSP. INDICA TOP | 1 | Unknown | Y | 0 | ||||||||||
125983651 | 12598365 | 4 | SS | LORAZEPAM. | LORAZEPAM | 1 | Unknown | U | 0 | ||||||||||
125983651 | 12598365 | 5 | C | LOPERAMIDE | LOPERAMIDE | 1 | 0 | ||||||||||||
125983651 | 12598365 | 6 | C | TEMAZEPAM. | TEMAZEPAM | 1 | 0 | ||||||||||||
125983651 | 12598365 | 7 | C | VENTOLIN | ALBUTEROL SULFATE | 1 | Respiratory (inhalation) | 0 | |||||||||||
125983651 | 12598365 | 8 | C | INSULIN | INSULIN NOS | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125983651 | 12598365 | 1 | Hepatitis C |
125983651 | 12598365 | 2 | Hepatitis C |
125983651 | 12598365 | 3 | Product used for unknown indication |
125983651 | 12598365 | 4 | Product used for unknown indication |
125983651 | 12598365 | 5 | Product used for unknown indication |
125983651 | 12598365 | 6 | Product used for unknown indication |
125983651 | 12598365 | 7 | Product used for unknown indication |
125983651 | 12598365 | 8 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125983651 | 12598365 | OT |
125983651 | 12598365 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125983651 | 12598365 | Abnormal behaviour | |
125983651 | 12598365 | Back pain | |
125983651 | 12598365 | Chest pain | |
125983651 | 12598365 | Confusional state | |
125983651 | 12598365 | Cough | |
125983651 | 12598365 | Decreased appetite | |
125983651 | 12598365 | Diarrhoea | |
125983651 | 12598365 | Disorientation | |
125983651 | 12598365 | Drug effect increased | |
125983651 | 12598365 | Drug interaction | |
125983651 | 12598365 | Dysarthria | |
125983651 | 12598365 | Dyspnoea | |
125983651 | 12598365 | Fatigue | |
125983651 | 12598365 | Insomnia | |
125983651 | 12598365 | Somnolence | |
125983651 | 12598365 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |